cemiplimab,ipilimumab
regeneron,sanofi,bms
['empower-lung 3', 'empower,lung,1', 'ipilimumab', ' ipi ', 'lung', 'nsclc', 'empower,lung,i', 'empower,lung,3', 'sclc', 'cemiplimab']
cemiplimab plus low dose ipi plus chemo in nsclc . os and pfs benifit. one more option for io plus chemo combination. low dose ipi is intresting. #esmoimmuno22 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists